TrialAnnals of the rheumatic diseases2004

Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement.

C Alessandri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.